Terumo SG&A Expenses 2012-2024 | TRUMY

Terumo sg&a expenses for the twelve months ending December 31, 2024 were $1.721B, a 14.91% decline year-over-year.

  • Terumo annual sg&a expenses for 2025 were $2.519B, a 5.82% increase from 2024.
  • Terumo annual sg&a expenses for 2024 were $2.38B, a 7.27% increase from 2023.
  • Terumo annual sg&a expenses for 2023 were $2.219B, a 0.63% decline from 2022.

Terumo SG&A Expenses 2012-2024 | TRUMY

  • Terumo annual sg&a expenses for 2025 were $2.519B, a 5.82% increase from 2024.
  • Terumo annual sg&a expenses for 2024 were $2.38B, a 7.27% increase from 2023.
  • Terumo annual sg&a expenses for 2023 were $2.219B, a 0.63% decline from 2022.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$216.5B
Boston Scientific (BSX)$153.5B
Stryker (SYK)$147.8B
EssilorLuxottica (ESLOY)$131.6B
Medtronic (MDT)$115B
Lonza Group Ag (LZAGY)$49.2B
Haleon (HLN)$42.8B
ResMed (RMD)$38.3B
GE HealthCare Technologies (GEHC)$34B
Agilent Technologies (A)$31.8B
Koninklijke Philips (PHG)$23.6B
Insulet (PODD)$19.8B
Zimmer Biomet Holdings (ZBH)$18.3B
Baxter (BAX)$14B
Smith & Nephew SNATS (SNN)$13.3B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$6.6B
Lantheus Holdings (LNTH)$5B
Prestige Consumer Healthcare (PBH)$3.7B
Perrigo (PRGO)$3.7B
Haemonetics (HAE)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.3B
ICU Medical (ICUI)$3B
LeMaitre Vascular (LMAT)$1.8B
QuidelOrtho (QDEL)$1.7B
AtriCure (ATRC)$1.4B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B